GLEN MARK PHARMACEUTICALS
⚠️ Moderate Risk
FEI: 3013011026 • IN • INDIA
FEI Number
3013011026
Location
IN
Country
INDIAAddress
UNIT II VILLAGE BHATTAN, , SOLAN, IN, , India
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/2/2021 | 62UDK99ANTI-TUSSIVE/COLD N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/2/2021 | 64HDK02GUAIFENESIN (EXPECTORANT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/3/2020 | 61WDJ04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/30/2017 | 66FCL99SUPPRESSANT N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/15/2017 | 61WDO99A-FUNGAL N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is GLEN MARK PHARMACEUTICALS's FDA import refusal history?
GLEN MARK PHARMACEUTICALS (FEI: 3013011026) has 5 FDA import refusal record(s) in our database, spanning from 9/15/2017 to 12/2/2021.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. GLEN MARK PHARMACEUTICALS's FEI number is 3013011026.
What types of violations has GLEN MARK PHARMACEUTICALS received?
GLEN MARK PHARMACEUTICALS has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about GLEN MARK PHARMACEUTICALS come from?
All FDA import refusal data for GLEN MARK PHARMACEUTICALS is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.